glp-1 vs sglt2 diabetes SGLT2i and RA therapy in type 1 and reno-vascular outcomes: a real-world study | Diabetologia GLP-1 Receptor Agonists and SGLT2

Genetic data provide further support for a causal link between GLP-1 RA use and reduced ED risk

doi: 10.1186/1743-7075-1-5

Is Gastroparesis From Ozempic Reversible

Probiotics show mixed results averaging 1-2 pounds in meta-analyses

MASLD is a growing problem worldwide and this trial will provide real hope for patients with MASH, said co-lead author Philip Newsome, director of the Roger Williams Institute of Liver Studies at Kings College London, in a statement from the university

Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials